RxDoctor Payments DataLook up a doctor →

Eric Smith, MD

Adult Reconstructive Orthopaedic Surgery · Boston, MANPI 1306859442

Payments from drug & device makers

$721,200in general payments, 2019–2025

Across 457 payments — averaging $1578.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$282K
  • Conformis, Inc.$196K
  • Medical Device Business Services, Inc.$195K
  • Pacira Therapeutics, Inc.$16K
  • Medacta USA, Inc.$10K
  • Pacira Pharmaceuticals Incorporated$9K
  • plus $14K from 20 others
$5,000in research payments, 2019–2025

Across 1 payment — averaging $5000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medacta USA, Inc.$5K

What the payments were for

  • Royalty or licence$203,95031%
  • Consulting fees$269,86742%
  • Speaking & faculty fees$33,6455%
  • Travel & lodging$34,9165%
  • Food & beverage$13,8322%
  • Ownership interest$92,78314%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$721,200 in reported general payments places this provider in the 85th percentile of 24 adult reconstructive orthopaedic surgery providers in Massachusetts.

See all adult reconstructive orthopaedic surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$384,643
Medicare patients
443
Services billed
930

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin30$58

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →